Moreover, we showed a negative correlation between IL-10 [MFI in CD4+] and IL-10 [MFI in CD4+CD25+] with ALT in MASLD, and a positive relationship between [MFI in CD4+] and AST/ALT ratio. Here, CD4 is linked to metabolic dysfunction-associated steatotic liver disease.